Characterization of rat C5a anaphylatoxin receptor (C5aR) : Cloning of rat C5aR cDNA and study of C5aR expression by rat astrocytes

Molecular Brain Research

Volumn 48, Issue 2, 1997, Pages 215-222

  Sayah, Sakina ^a   Patte, Christine ^a   Gasque, Philippe ^b   Chan, Philippe ^a   Ischenko, Alexander ^c   Vaudry, Hubert ^a   Fontaine, Marc ^a  

^a INSERM   (France)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c State Research Institute of Highly Pure Biopreparations   (Russian Federation)

Author keywords

Astrocyte; C5a anaphylatoxin receptor; cDNA; Central nervous system; Microfluorimetry; Rat; RT PCR

Indexed keywords

ANAPHYLATOXIN; COMPLEMENT RECEPTOR; COMPLEMENTARY DNA; LEUKOTRIENE RECEPTOR;

ANIMAL TISSUE; ARTICLE; ASTROCYTE; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; CONTROLLED STUDY; GLIA CELL; HUMAN; HUMAN TISSUE; INFLAMMATION; MOLECULAR CLONING; NERVOUS SYSTEM; NONHUMAN; NORTHERN BLOTTING; PATHOGENESIS; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TARGET CELL;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD; ASTROCYTES; BASE SEQUENCE; CLONING, MOLECULAR; COMPLEMENT C5A; DNA, COMPLEMENTARY; HUMANS; MICE; MOLECULAR SEQUENCE DATA; RATS; RATS, WISTAR; RECEPTOR, ANAPHYLATOXIN C5A; RECEPTORS, COMPLEMENT; RNA, MESSENGER; SEQUENCE HOMOLOGY, AMINO ACID;

ANIMALIA;

EID: 0030862079     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(97)00094-6     Document Type: Article

References (38)

1. Boulay F., Mery L., Tardif M., Brouchon L., Vignais P. Expression cloning of a receptor for C5a anaphylatoxin on differentiated HL-60 cells. Biochemistry. 30:1991;2993-2999.
2. Buchner R.R., Hugli T.E., Ember J.A., Morgan E.L. Expression of functional receptors for human C5a anaphylatoxin (CD88) on the human hepatocellular carcinoma cell line HepG2. J. Immunol. 155:1995;308-315.
3. Chenoweth D.E., Goodman M.G., Weigle W.O. Demonstration of a specific receptor for human C5a anaphylatoxin on murine macrophages. J. Exp. Med. 156:1982;68-78.
4. Compston D.A.S., Morgan B.P., Campbell A.K., Wilkins P., Cole G., Thomas N.D., Jasani B. Immunocytochemical localization of the terminal complement complex in multiple sclerosis. Neuropathol. Appl. Neurobiol. 15:1989;307-316.
5. Faustmann P.M., Krause D., Dux R., Dermietzel R. Morphological study in the early stages of complement C5a fragment-induced experimental meningitis: activation of macrophages and astrocytes. Acta Neuropathol. 89:1995;239-247.
6. Frank M.M., Fries L.F. Complement interactions and functions: the role of complement in inflammation and phagocytosis. Immunol. Today. 12:1991;322-326.
7. Gasque P., Julen N., Ischenko A., Picot C., Mauger C., Chauzy C., Ripoche J., Fontaine M. Expression of complement components of the alternative pathway by glioma cell lines. J. Immunol. 149:1992;1381-1387.
8. Gasque P., Ischenko A., Legoedec J., Mauger C., Schouft M.T., Fontaine M. Expression of the complement classical pathway by human glioma in culture. A model for complement expression by nerve cells. J. Biol. Chem. 268:1993;25068-25074.
9. Gasque P., Fontaine M., Morgan B.P. Complement expression in human brain. Biosynthesis of terminal pathway components and regulators in human glial cells and cell lines. J. Immunol. 154:1995;4726-4733.
10. Gasque P., Chan P., Fontaine M., Ischenko A., Lamacz M., Götze O., Morgan B.P. Identification and characterization of the complement C5a anphylatoxin receptor on human astrocytes: relevance to inflammation in the brain. J. Immunol. 155:1995;4882-4889.
11. Gerard N.P., Hodges M.K., Drazen J.M., Weller P.F., Gerard C. Characterization of a receptor for C5a anaphylatoxin on human eosinophils. J. Biol. Chem. 264:1989;1760-1766.
12. Gerard N.P., Gerard C. The chemotactic receptor for human C5a anaphylatoxin. Nature. 349:1991;614-617.
13. Gerard C., Bao L., Orozco O., Pearson M., Kunz D., Gerard N.P. Structural diversity in the extracellular faces of peptidergic G-protein coupled receptors. Molecular cloning of the mouse anaphylatoxin receptor. J. Immunol. 149:1992;2600-2606.
14. Gordon D.L., Avery V.M., Adrian D.L., Sadlon T.A. Detection of complement protein mRNA in human astrocytes by the polymerase chain reaction. J. Neurosci. Methods. 45:1992;191-197.
15. Gordon D.L., Sadlon T.A., Wesselingh S.L., Russell S.M., Johnstone R.W., Purcell D.F.J. Human astrocytes express membrane cofactor protein (CD46), a regulator of complement activation. J. Neuroimmunol. 36:1992;199-208.
16. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260:1985;3440-3450.
17. Haviland D.L., MacCoy R.L., Whitehead W.T., Akama H., Molmenti E.P., Brown A., Haviland J.C., Parks W.C., Perlmutter D.H., Wetsel R.A. Cellular expression of the C5a anaphylatoxin receptor (C5aR): demonstration of C5aR on non myeloid cells of the liver and lung. J. Immunol. 154:1995;1861-1869.
18. Höpken U.E., Bao L., Gerard N.P., Gerard C. The C5a chemoattractant receptor mediates mucosal defence to infection. Nature (London). 383:1996;86-89.
19. Huey R., Hugli T.E. Characterization of a C5a receptor on human polymorphonuclear leukocytes. J. Immunol. 135:1985;2063-2068.
20. Johnson S.A., Lampert-Etchells M., Pasinetti G.M., Rozovsky I., Finch C.E. Complement mRNAs in the mammalian brain: responses to Alzheimer's disease and experimental brain lesioning. Neurobiol. Aging. 13:1992;641-648.
21. Lacy M., Jones J., Whittemore S.R., Haviland D.L., Wetsel R.A., Barnum S.R. Expression of receptors for the C5a anaphylatoxin, interleukin-8 and FMLP by human astrocytes and microglia. J. Neuroimmunol. 61:1995;71-78.
22. Lévi-Strauss M., Mallat M. Primary cultures of murine astrocytes produce C3 and factor B, two components of the alternative pathway of complement activation. J. Immunol. 139:1987;2361-2366.
23. Linington C., Morgan B.P., Scolding N.J., Piddlesden S., Wikins P., Compston D.A.S. The role of complement in the pathogenesis of experimental allergic encephalomyelitis. Brain. 112:1989;895-911.
24. MacCoy R., Haviland D.L., Molmenti E.P., Ziambaras T., Wetsel R.A., Perlmutter D.H. N-Formylpeptide and complement C5a recptors are expressed in liver cells and mediate acute phase gene regulation. J. Exp. Med. 182:1995;207-217.
25. Marder S.R., Chenoweth D.E., Goldstein I.M., Perez H.D. Chemotactic responses of human peripheral blood monocytes to the complement-derived peptides C5a and C5a-desarg. J. Immunol. 134:1985;3325-3331.
26. B.P. Morgan, Complement in diseases of the central nervous system, in: K. Whaley et al. (Eds.), Complement in Health and Disease, Kluwer, Dordrecht, The Netherlands.
27. Pasinetti G.M., Johnson S.A., Rozovsky I., Lampert-Etchells M., Morgan D.G., Gordon M.N., Morgan T.E., Willoughby D., Finch C.E. Complement C1qB and C4 mRNAs responses to lesioning in rat brain. Exp. Neurol. 118:1992;117-125.
28. Piddlesden S.J., Morgan B.P. Killing of rat glial cells by complement components: deficiency of the rat analogue CD59 is the cause of oligodendrocyte susceptibility to lysis. J. Neuroimmunol. 48:1993;169-176.
29. Piddlesden S.J., Storch M.K., Hibbs M., Freeman A.M., Lassman H., Morgan B.P. Soluble recombinant complement receptor 1 inhibits inflammation and demyelination in antibody-mediated demyelinating experimental allergic encephalomyelitis. J. Immunol. 152:1994;5477-5484.
30. Rogers J., Cooper N.R., Webster S., Schultz J., McGeer P.L., Styren S.D., Civin W.H., Brachova L., Bradt B., Ward P., Lieberburg I. Complement activation by β-amyloid in Alzheimer disease. Proc. Natl. Acad. Sci. USA. 89:1992;10016-10020.
31. i complex. Proc. Natl. Acad. Sci. USA. 88:1991;971-975.
32. J. Sambrook, E.F. Fritsch and T. Maniatis, Molecular Cloning, A Laboratory Manual, 2nd edn., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, vol. 1, pp. 7.19-7.22.
33. z proteins. Biophys. Biochem. Res. Commun. 208:1995;223-229.
34. Svensson M., Aldskogius H. Evidence for activation of the complement cascade in the hypoglossal nucleus following peripheral nerve injury. J. Neuroimmunol. 40:1992;99-110.
35. i in U937-cells and in cells transfected with C5a receptor cDNA. Mol. Pharmacol. 46:1994;832-839.
36. Walker D.G., McGeer P.L. Complement gene expression in human brain: comparison between normal and Alzheimer disease cases. Mol. Brain Res. 14:1992;109-116.
37. Wren D.R., Noble M. Oligodendrocytes and oligodendrocyte/type-2 astrocyte progenitor cells of adult rats are specifically susceptible to the lytic effects of complement in absence of antibody. Proc. Natl. Acad. Sci. USA. 86:1989;9025-9029.
38. Yang C., Jones L.J., Barnum S.R. Expression of decay-accelerating factor (CD55), membrane cofactor protein (CD46) and CD59 in human astroglioma cell line, D54-MG, and primary rat astrocytes. J. Neuroimmunol. 47:1993;123-132.